U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

Singh, H., Walker, A. J., Amiri-Kordestani, L., Cheng, J., Tang, S., Balcazar, P., Barnett-Ringgold, K., Palmby, T. R., Cao, X., Zheng, N., Liu, Q., Yu, J., Pierce, W. F., Daniels, S. R., Sridhara, R., Ibrahim, A., Kluetz, P. G., Blumenthal, G. M., Beaver, J. A., Pazdur, R.
The American Association for Cancer Research (AACR)
Published 2018